Annual Net Income
-$311.90 M
-$14.52 M-4.88%
December 31, 2022
Summary
- As of February 10, 2025, RETA annual net profit is -$311.90 million, with the most recent change of -$14.52 million (-4.88%) on December 31, 2022.
- During the last 3 years, RETA annual net income has fallen by -$21.73 million (-7.49%).
Performance
RETA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Net Income
$193.00 M
+$309.12 M+266.21%
June 30, 2023
Summary
- As of February 10, 2025, RETA quarterly net profit is $193.00 million, with the most recent change of +$309.12 million (+266.21%) on June 30, 2023.
- Over the past year, RETA quarterly net income has increased by +$266.55 million (+362.39%).
Performance
RETA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Net Income
-$87.62 M
+$266.55 M+75.26%
June 30, 2023
Summary
- As of February 10, 2025, RETA TTM net profit is -$87.62 million, with the most recent change of +$266.55 million (+75.26%) on June 30, 2023.
- Over the past year, RETA TTM net income has increased by +$217.00 million (+71.24%).
Performance
RETA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RETA Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -4.9% | +362.4% | +71.2% |
3 y3 years | -7.5% | +385.6% | +74.5% |
5 y5 years | -554.3% | +784.1% | +69.8% |
RETA Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | +4.9% | at low | at high | -160.2% | at high | +304.2% |
5 y | 5-year | +25.9% | at low | at high | -196.9% | at high | +321.0% |
alltime | all time | <-9999.0% | at low | at high | -196.9% | -6934.9% | +321.0% |
Reata Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | $193.00 M(-266.2%) | -$87.62 M(-75.3%) |
Mar 2023 | - | -$116.12 M(+35.8%) | -$354.18 M(+13.6%) |
Dec 2022 | -$311.90 M(+4.9%) | -$85.50 M(+8.2%) | -$311.90 M(+0.0%) |
Sep 2022 | - | -$79.00 M(+7.4%) | -$311.78 M(+2.3%) |
Jun 2022 | - | -$73.56 M(-0.4%) | -$304.63 M(+0.3%) |
Mar 2022 | - | -$73.84 M(-13.5%) | -$303.77 M(+2.1%) |
Dec 2021 | -$297.39 M(+20.0%) | -$85.39 M(+18.8%) | -$297.39 M(+7.1%) |
Sep 2021 | - | -$71.85 M(-1.2%) | -$277.78 M(+2.4%) |
Jun 2021 | - | -$72.70 M(+7.8%) | -$271.39 M(+1.9%) |
Mar 2021 | - | -$67.45 M(+2.6%) | -$266.27 M(+7.5%) |
Dec 2020 | -$247.75 M(-14.6%) | -$65.78 M(+0.5%) | -$247.75 M(-32.8%) |
Sep 2020 | - | -$65.46 M(-3.1%) | -$368.92 M(+7.5%) |
Jun 2020 | - | -$67.58 M(+38.1%) | -$343.16 M(+10.7%) |
Mar 2020 | - | -$48.94 M(-73.8%) | -$309.95 M(+6.8%) |
Dec 2019 | -$290.17 M(+260.3%) | -$186.94 M(+371.0%) | -$290.17 M(+125.3%) |
Sep 2019 | - | -$39.69 M(+15.5%) | -$128.81 M(+7.4%) |
Jun 2019 | - | -$34.38 M(+17.9%) | -$119.95 M(+5.4%) |
Mar 2019 | - | -$29.15 M(+14.0%) | -$113.78 M(+41.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2018 | -$80.55 M(+69.0%) | -$25.58 M(-17.0%) | -$80.55 M(+12.4%) |
Sep 2018 | - | -$30.84 M(+9.3%) | -$71.64 M(+34.9%) |
Jun 2018 | - | -$28.21 M(-791.1%) | -$53.12 M(+45.5%) |
Mar 2018 | - | $4.08 M(-124.5%) | -$36.49 M(-23.5%) |
Dec 2017 | -$47.67 M(+665.6%) | -$16.68 M(+35.5%) | -$47.67 M(+35.7%) |
Sep 2017 | - | -$12.31 M(+6.2%) | -$35.13 M(+48.1%) |
Jun 2017 | - | -$11.59 M(+63.3%) | -$23.72 M(+81.5%) |
Mar 2017 | - | -$7.10 M(+71.6%) | -$13.07 M(+109.8%) |
Dec 2016 | -$6.23 M(+329.4%) | -$4.14 M(+361.1%) | -$6.23 M(+62.3%) |
Sep 2016 | - | -$897.00 K(-4.2%) | -$3.84 M(+66.3%) |
Jun 2016 | - | -$936.00 K(+262.8%) | -$2.31 M(-24.8%) |
Mar 2016 | - | -$258.00 K(-85.2%) | -$3.07 M(+111.4%) |
Dec 2015 | -$1.45 M(-310.4%) | -$1.75 M(-375.8%) | -$1.45 M(-759.1%) |
Sep 2015 | - | $633.00 K(-137.3%) | $220.00 K(-153.3%) |
Jun 2015 | - | -$1.70 M(-224.8%) | -$413.00 K(-132.2%) |
Mar 2015 | - | $1.36 M(-1886.8%) | $1.28 M(-1786.8%) |
Dec 2014 | $689.00 K(-102.0%) | -$76.00 K | -$76.00 K |
Dec 2013 | -$35.10 M | - | - |
FAQ
- What is Reata Pharmaceuticals annual net profit?
- What is the all time high annual net income for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals annual net income year-on-year change?
- What is Reata Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals quarterly net income year-on-year change?
- What is Reata Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Reata Pharmaceuticals?
- What is Reata Pharmaceuticals TTM net income year-on-year change?
What is Reata Pharmaceuticals annual net profit?
The current annual net income of RETA is -$311.90 M
What is the all time high annual net income for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high annual net profit is $689.00 K
What is Reata Pharmaceuticals annual net income year-on-year change?
Over the past year, RETA annual net profit has changed by -$14.52 M (-4.88%)
What is Reata Pharmaceuticals quarterly net profit?
The current quarterly net income of RETA is $193.00 M
What is the all time high quarterly net income for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high quarterly net profit is $193.00 M
What is Reata Pharmaceuticals quarterly net income year-on-year change?
Over the past year, RETA quarterly net profit has changed by +$266.55 M (+362.39%)
What is Reata Pharmaceuticals TTM net profit?
The current TTM net income of RETA is -$87.62 M
What is the all time high TTM net income for Reata Pharmaceuticals?
Reata Pharmaceuticals all-time high TTM net profit is $1.28 M
What is Reata Pharmaceuticals TTM net income year-on-year change?
Over the past year, RETA TTM net profit has changed by +$217.00 M (+71.24%)